The best care for patients today—and tomorrow

Photo: Dr. Lena Quilty

A CAMH-developed model to treat the agitation and aggression experienced by more than 80 per cent of people with Alzheimer’s disease is being tested at seven sites across Canada, thanks to support from Brain Canada and the Centre for Aging and Brain Health Innovation.

“There’s been an improvement in the management of aggression and agitation in our patients,” says Dr. Peter Derkach, Medical Director at the Ukrainian Canadian Care Centre, which participated in the pilot study.

In related efforts, a CAMH team is using brain stimulation to better understand why some people with Alzheimer’s disease experience agitation. The findings could lead to the development of a new safe and effective treatment for this population.

Photo: Lillian Duda